Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Fresenius Kabi Swissbiosim Gmbh, explained in plain language.
This study is observing 600 people with moderate to severe rheumatoid arthritis who are already prescribed a medication called Tyenne. Researchers will follow these patients for 12 months to see how many continue taking the drug and if their arthritis symptoms improve. The goal i…
Sponsor: Fresenius Kabi SwissBioSim GmbH • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC